Nexalin Technology, Inc.
NASDAQ · us_market
No AI insight generated yet for this ticker.
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer's disease, and dementia. Nexalin Technology, Inc. is headquartered in Houston, Texas.
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| StateStreet | passive | 32.3K | $11.25K | 0.00% | Unchanged | 2026-03-31 |
| RenTech | quant | 10.7K | $3.72K | 0.00% | Trimmed-91.3% | 2026-03-31 |
| FidelityFMR | fundamental | 1.5K | $522 | 0.00% | Trimmed-95.3% | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-05-08 | -0.10 | -0.11 | -10.00% |
| 2026-03-25 | -0.12 | -0.13 | -8.33% |
| 2025-11-14 | -0.12 | -0.13 | -8.33% |
| 2025-08-06 | -0.14 | -0.10 | +28.57% |
| 2025-05-13 | -0.10 | -0.15 | -50.00% |
| 2025-03-14 | -0.12 | -0.28 | -133.33% |
| 2024-11-08 | -0.12 | -0.23 | -91.67% |
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| NXL | +60.53% | +36.77% | +9.32% | -48.74% |
| XLV | +2.97% | -4.64% | -3.44% | +12.69% |
| Alpha (stock − sector) | +57.56% | +41.41% | +12.76% | -61.43% |